CTRI/2019/12/022211尚未招募不适用
Hemodynamic resuscitation and monitoring in early sepsis - A multicentric observational study on practice patterns of hemodynamic resuscitation in septic shock
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 450
- 试验地点
- 1
- 主要终点
- Completing the elements of the one hour SSC sepsis bundle in one 1 hour
研究概览
简要总结
It is a multi centric observational single arm cohort study. The purpose of the study is to monitor the fluid resuscitation practice in the initial period of sepsis and the various monitoring technique involved in various ICUs across India. It also analyses the 28 day mortality resulted from the different resuscitation practices done during the study period.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 90.00 Year(s)（—）
- 性别
- All
入选标准
- •any patient admitted with septic shock not maintaining mean arterial pressure of 65 mm Hg without vasopressors.
排除标准
- •cardiogenic/obstructive/hemorrhagic shock do not resuscitate/do not intubate patients admission from other ICU/hospital with more than 7 days stay in that ICU/hospital.
结局指标
主要结局
Completing the elements of the one hour SSC sepsis bundle in one 1 hour
时间窗: 1 hour
次要结局
- Hospital mortality/28-day mortality whichever is earlier(Completing the elements of the one hour SSC sepsis bundle in one three hour)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Study of MIcrocirculatory Perfusion Alterations in Severe Burn InjuryMicrocirculationBurnsResuscitationNCT04500197Maasstad Hospital21
Unknown
不适用
Clinical Evaluation of the Vital Signs Monitoring System (VSMS)Body TemperatureOxygen SaturationRespirationECGNCT03206528G Medical Innovations Ltd.100
终止
不适用
OLIF25™ /OLIF51™ StudyDegenerative Disc DiseaseScoliosisNCT02657421Medtronic Spinal and Biologics168
已完成
4 期
Harmonic ACE®+7 Shears in Laparoscopic HysterectomyBenign Disease Where Total Hysterectomy is IndicatedNCT02278640Ethicon Endo-Surgery40
已完成
不适用
Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in ChinaType 2 Diabetes MellitusNCT03156985AstraZeneca3,000